Literature DB >> 23772044

Tigecycline: an antibiotic for the twenty-first century.

Matthew Dryden1.   

Abstract

This Supplement in the Journal of Antimicrobial Chemotherapy comprises a series of papers reporting on 'real-life' clinical experience with tigecycline. The data reported are derived from five European observational studies on the use of tigecycline, either as monotherapy or in combination with other antibiotics, for the treatment of complicated skin and soft-tissue infections or complicated intra-abdominal infections. Taken together, this collection of articles gives clinical insight into the use of tigecycline for the treatment of complicated infections.

Entities:  

Keywords:  anti-infective development; antibiotics; tetracyclines

Mesh:

Substances:

Year:  2013        PMID: 23772044     DOI: 10.1093/jac/dkt139

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  2 in total

1.  Tigecycline treatment causes a decrease in fibrinogen levels.

Authors:  Qian Zhang; Suming Zhou; Jing Zhou
Journal:  Antimicrob Agents Chemother       Date:  2014-12-29       Impact factor: 5.191

2.  Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study.

Authors:  Milo Gatti; Emanuel Raschi; Fabrizio De Ponti
Journal:  BMC Pharmacol Toxicol       Date:  2019-11-12       Impact factor: 2.483

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.